|
gptkbp:instanceOf
|
patent
|
|
gptkbp:communityFeedback
|
positive
|
|
gptkbp:hasAbstract
|
A method for enhancing gene expression.
|
|
gptkbp:hasApplicationNumber
|
US_16/123,456
|
|
gptkbp:hasAssignee
|
gptkb:Tech_Innovations_LLC
|
|
gptkbp:hasAwards
|
collaborative.
innovative solutions.
|
|
gptkbp:hasCitations
|
US_28,901,258_T20_Family
|
|
gptkbp:hasClaim
|
20
|
|
gptkbp:hasCollaborationsWith
|
with_BioTech_Corp.
|
|
gptkbp:hasCompetitors
|
unique technology
dynamic.
|
|
gptkbp:hasContribution
|
optimistic.
partnerships.
direct sales.
|
|
gptkbp:hasCustomerBase
|
hospitals.
|
|
gptkbp:hasDescription
|
This patent describes a novel method for gene editing.
|
|
gptkbp:hasDeveloped
|
preclinical
|
|
gptkbp:hasExhibition
|
acquisition.
|
|
gptkbp:hasFacility
|
T20 family
|
|
gptkbp:hasFeature
|
favorable.
investors.
promising.
|
|
gptkbp:hasFieldOfUse
|
medical applications
|
|
gptkbp:hasFilingDate
|
2020-01-15
|
|
gptkbp:hasFilm
|
global
|
|
gptkbp:hasFunding
|
gptkb:National_Institutes_of_Health
grants
high.
|
|
gptkbp:hasGoals
|
granted
|
|
gptkbp:hasImpactOn
|
high
|
|
gptkbp:hasInternationalClassification
|
C12N_15/00
|
|
gptkbp:hasInventor
|
gptkb:John_Doe
Jane_Smith
|
|
gptkbp:hasLegalEvent
|
maintenance fee paid
|
|
gptkbp:hasLocalCuisine
|
NCT01234567
|
|
gptkbp:hasLocation
|
leading innovator.
|
|
gptkbp:hasOccupation
|
approved
pending
IPO.
|
|
gptkbp:hasPartnershipsWith
|
gptkb:Pharma_Inc.
in development
with academic institutions
collaborations.
Venture_Capital_Firm.
|
|
gptkbp:hasPersonnel
|
exclusive license
|
|
gptkbp:hasPriorityDate
|
2019-01-15
2040-01-15
|
|
gptkbp:hasPublications
|
2021-07-20
|
|
gptkbp:hasRelatedPatent
|
incremental
US_28,901,258_T20_Family
|
|
gptkbp:hasResearchInterest
|
gptkb:Harvard_University
molecular biology
gene therapy
conducted.
|
|
gptkbp:hasSpecialty
|
patent portfolio
FDA_approval
|
|
gptkbp:hasSustainabilityInitiatives
|
positive
|
|
gptkbp:hasTechnicalField
|
genetic engineering
|
|
gptkbp:hasTechnology
|
6
ongoing
high complexity
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 28,901,259 T20 Family
|
|
gptkbp:isCitedBy
|
gptkb:US_29,123,456_B2
|
|
gptkbp:isFiledIn
|
gptkb:United_States
|
|
gptkbp:isPartOf
|
T20 patent family
|
|
gptkbp:isPublishedIn
|
US 2021/0212345 A1
|
|
gptkbp:isRelatedTo
|
US_28,901,258_T20_Family
|
|
gptkbp:localBusiness
|
B2B.
|
|
gptkbp:market
|
high
large
licensing
therapeutics
moderate.
healthcare.
regulatory changes.
growing demand.
|
|
gptkbp:streamingPlatforms
|
licensing fees.
|
|
gptkbp:usesTechnology
|
biotechnology
|